Bronchoalveolar lavage fluid cytokine-based clustering identifies prognostically relevant cytokine phenotypes across interstitial lung diseases
BACKGROUND: Existing classification systems for interstitial lung diseases (ILDs) are limited and do not fully reflect the underlying biological drivers. We sought to identify cytokine-defined ILD subgroups based on bronchoalveolar lavage fluid (BALF) cytokine profiles and to examine their clinical relevance, particularly their association with prognosis. METHODS: We reanalyzed a BALF cytokine dataset from 84 patients with ILDs, including idiopathic pulmonary fibrosis (IPF), idiopathic nonspecific interstitial pneumonia (iNSIP), cryptogenic organizing pneumonia, sarcoidosis, idiopathic inflammatory myopathy-associated ILD, and RA-ILD. Cytokine concentrations were measured using a multiplex bead-based assay. We used hierarchical clustering, principal component, correspondence, cosine similarity, and discriminant analyses to identify cytokine-defined subgroups and examine their clinical associations. RESULTS: We identified three cytokine-level-defined clusters: Clusters 1, 2, and 3, characterized by globally high, intermediate, and low cytokine levels, respectively. Clusters 1 and 3 were associated with poor and favorable prognoses, respectively. Cytokine-defined clusters did not fully correspond with conventional disease categories, although Cluster 3 predominantly included patients with sarcoidosis. RA-ILD was mainly distributed in Clusters 1 and 2 together with IPF, iNSIP, COP, and IIM-ILD. However, RA-ILD was distinguished by relatively elevated interleukin-17 and granulocyte-macrophage colony-stimulating factor levels. CONCLUSIONS: BALF cytokine profiling can identify cytokine intensity-defined ILD subgroups that are associated with prognosis and are not fully captured by conventional disease classification. Although RA-ILD shares cytokine features with IPF and iNSIP, it also exhibits distinct immune characteristics. These findings suggest that intrapulmonary cytokine profiling could facilitate ILD stratification.
Authors
- Wataru Fujii (ORCID: https://orcid.org/0000-0002-1633-8255)
- Tomoyuki Miyao (ORCID: https://orcid.org/0000-0002-8769-2702)
- Kazuhiro Kurasawa (ORCID: https://orcid.org/0000-0001-6024-7556)
- Takayoshi Owada (ORCID: https://orcid.org/0000-0003-3457-0207)
- Masafumi Arima (ORCID: https://orcid.org/0000-0002-5169-7536)
- Satoko Arai (ORCID: https://orcid.org/0000-0002-6145-8686)
- Reika Maezawa
- Kei Ikeda (ORCID: https://orcid.org/0000-0003-0574-9611)
- Ayae Tanaka
Institutions
- Dokkyo Medical University Saitama Medical Center (JP)
- Dokkyo Medical University (JP)
Publication Details
- Journal
- Respiratory Investigation
- Published
- 2026-09-18
- DOI
- https://doi.org/10.1016/j.resinv.2026.101511
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AbbVie